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Abstract
Background: Syndromic surveillance is increasingly being evaluated for its potential for early
warning of increased disease activity in the population. However, interpretation is hampered by the
difficulty of attributing a causative pathogen. We described the temporal relationship between
laboratory counts of influenza and respiratory syncytial virus (RSV) detection and alternative
groupings of Emergency Department (ED) respiratory diagnoses.
Methods: ED and laboratory data were obtained for the south-eastern area of Sydney, NSW for
the period 1 June 2001 - 1 December 2006. Counts of ED visits and laboratory confirmed positive
RSV and influenza cases were aggregated by week. Semi-parametric generalized additive models
(GAM) were used to determine the association between the incidence of RSV and influenza and
the incidence of respiratory syndrome ED presentations while controlling for temporal
confounders.
Results: For every additional RSV laboratory count, ED diagnoses of bronchiolitis increased by
3.1% (95%CI: 2.7%-3.5%) in the same week. For every additional influenza laboratory count, ED
diagnoses of influenza-like illness increased by 4.7% (95%CI: 4.2%-5.2%) one week earlier.
Conclusion: In this study, large increases in ED diagnoses of bronchiolitis and influenza-like illness
were independent and proxy indicators for RSV and influenza activity, respectively.
Background
Syndromic surveillance is increasingly being used for
monitoring disease activity because of its potential for
early detection of outbreaks and epidemics [1-6], and its
potentially widespread coverage of target populations.
However, interpretation of surveillance signals is often
hampered by the difficulty of implicating a causative
pathogen. There is a need to understand whether and how
syndromic surveillance can distinguish between specific
pathogens circulating in the population.
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In temperate climate zones, emergency department visits
for respiratory conditions such as bronchiolitis, influenza-
like illness, and pneumonia have been found to display a
distinctly seasonal pattern, with ED visits peaking in the
winter months [7,8]. Previous studies have found that
influenza virus and respiratory syncytial virus (RSV)
explain most of the variation in presentations of respira-
tory syndromes to EDs [9,10,7], but these studies did not
determine whether syndromic surveillance could distin-
guish between these viruses.
RSV is the most common cause of lower respiratory tract
infection in infants and children worldwide and often
manifests as bronchiolitis and pneumonia [11,12].
Almost all children have been infected with RSV by two
years of age and re-infection throughout life is common.
In adults, RSV is increasingly recognized as an important
cause of serious respiratory disease in the elderly and
immuno-compromised individuals [11]. In younger, oth-
erwise healthy adults, RSV may have a clinical presenta-
tion similar to influenza [13].
Apart from causing typical influenza syndromes, influ-
enza viruses have a well-established relationship with
pneumonia morbidity and mortality [14] and can also be
a cause of bronchiolitis [15] in younger children. There is
strong evidence that RSV and influenza co-circulate [14]
and co-infection is possible [16].
Another important consideration for syndromic surveil-
lance is whether it can offer earlier warning of disease
activity than surveillance of specific pathogens. Our previ-
ous work found at least a 3 day advantage of monitoring
daily counts of emergency department diagnoses of influ-
enza compared with laboratory surveillance of influenza
[8]. Wijngaard et al [9] found between 0 and 5 weeks
advantage for alternative respiratory illness syndromes
compared with influenza, and between 3 weeks disadvan-
tage and 2 weeks advantage for the same syndromes
against laboratory-confirmed RSV. However, the respira-
tory syndromes were non-specific and did not discrimi-
nate between those pathogens.
No studies, to our knowledge, have investigated whether
surveillance of ED diagnoses of specific respiratory syn-
dromes can distinguish between different causative path-
ogens circulating in the population. Hence, this time
series study aimed to determine how RSV and influenza
virus activity in the population affect alternative ED-based
respiratory syndrome definitions in terms of the degree of
association and timing. Understanding this relationship
between ED syndromes and underlying viral activity may
help in interpreting increases in syndrome activity
observed in syndromic surveillance.
Methods
Setting and data sources
RSV is not a notifiable/reportable condition in New South
Wales (NSW), Australia. However, we obtained RSV labo-
ratory data from public hospital laboratories participating
in the Eastern Sydney Laboratory Surveillance Program,
which covers the south-eastern area of Sydney. Influenza
is required to be notified by laboratories to the NSW
Department of Health [17] and was thus obtained from
the NSW Notifiable Diseases Database. Records were
selected if the notifying public health unit was within the
south-eastern area of Sydney. ED data was obtained from
the NSW Emergency Department Data Collection [18]
derived from the six public hospitals in the same geo-
graphic area. The ED data collection is drawn from data
entered in information systems in NSW EDs used by ED
personnel for patient management. The longest time
period of available data common to all datasets was 1st
June 2001 - 1st December 2006.
Syndrome definitions
Syndrome definitions were based on those used in exist-
ing ED-based syndromic surveillance in NSW [4]. The sys-
tem defines syndromes using provisional primary
diagnoses selected in patient management information
systems used in EDs. These information systems automat-
ically record the corresponding International Classifica-
tion of Diseases (ICD) Version 9 or 10 code, depending
on the information system used. "Bronchiolitis syn-
drome" was defined as ED presentations assigned a diag-
nosis of bronchiolitis (ICD-9-CM code 466.1, or ICD-10-
AM code J21). "Pneumonia syndrome" was defined as a
diagnosis of pneumonia (ICD-9-CM codes 480-486, or
ICD-10-AM codes J12-J18). "Influenza-like syndrome"
was defined as a diagnosis of influenza (ICD-9-CM code
487, or ICD-10-AM codes J10 and J11). "All acute respira-
tory infection" syndrome included diagnoses of whoop-
ing cough, acute upper respiratory infections, influenza
and pneumonia, other acute lower respiratory infections,
and cough (ICD -9-CM: 033, 460-466, 480-487, 786.2;
ICD-10-AM: A37, J00-J22, R05). "All respiratory syn-
drome" consisted of the respiratory conditions men-
tioned above as well as asthma, chronic obstructive
pulmonary disease, respiratory distress or arrest, other
breathing difficulties, and respiratory conditions during
the perinatal period (ICD-9-CM: 033, 460-519, 768-770,
799.1, 786.09, 786.2; ICD-10-AM: A37, J00-J99, P20-P28,
R09.2, R06.8, R05).
Analysis
Counts of ED visits and laboratory confirmed positive
RSV and influenza cases were aggregated by week. Week of
ED visit was used for the ED time series and the week of
specimen collection was used for the laboratory series.
Semi-parametric generalized additive models (GAM) wereBMC Infectious Diseases 2009, 9:190 http://www.biomedcentral.com/1471-2334/9/190
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used to determine the association between the incidence
of RSV and influenza and the incidence of respiratory syn-
drome ED presentations. GAMs extend traditional GLMs
by replacing linear predictors of the form:
η = ∑jβjχj with η = ∑jfj(χj) where fj(χj) can be nonparamet-
ric smooth functions [19,20], thus incorporating the flex-
ibility of nonparametric regression while still retaining
the interpretability of GLMs [21]. Alternative methods,
such as Poisson regression (without the use of a spline)
but with the inclusion of a covariate to control for season-
ality have been used in other studies [22], but were unable
to remove autocorrelation in the residuals in our data. The
non-parametric flexibility of GAMs has resulted in their
widespread use in time-series studies to adjust for the
nonlinear confounding effects of seasonality and trend
[19,23-27].
The counts of ED visits were assumed to follow a Poisson
distribution. Five models were constructed - one for each
ED syndrome: bronchiolitis, pneumonia, influenza-like,
all acute respiratory infections, and all respiratory visits.
The outcome in each model was the time-series of weekly
ED visits for the syndrome.
In each model, laboratory counts of RSV and influenza
were included as predictors, as well as a non-parametric
spline term for time (in weeks) to control for seasonal and
secular trends. These factors need to be controlled because
they produce autocorrelation (serial dependence) in the
model residuals. Like our previous study of just influenza,
we used natural cubic smoothing splines to control for
autocorrelation and trend [8]. Failure to control for these
factors can lead to incorrect inference in time series anal-
ysis. Because this study was using weekly rather than daily
time increments, we used 4 degrees of freedom per year in
the splines as this was sufficient for removing autocorrela-
tion in the residuals for most of the time series we exam-
ined. This effectively removed variation occurring over
more than a quarterly period and was a good balance
between removing too much trend and leaving too little
short-term variation in the time series. Autocorrelation
was assessed by visual inspection of autocorrelation plots
and p-values using the ARIMA procedure in SAS version
9.1.
Where the spline was insufficient to remove autocorrela-
tion from the model residuals an autoregressive term (the
previous week's ED syndrome count) was included in the
model to remove this residual autocorrelation. This was
necessary for the all acute respiratory infections syndrome
and the all respiratory syndrome models. Not removing
this residual autocorrelation would result in a failure of
the modelling assumption of independence in the residu-
als and thus to incorrect inference.
The modelling was completed in two stages. The first stage
was to determine the time lag in weeks that produced the
strongest association between each single laboratory time
series and the ED syndrome. The lag which produced the
strongest association was taken to be the relative risk
which was furthest from unity. The second stage was to
include the lag producing the strongest association in a
final model that included both RSV and influenza as
explanatory variables. The lag could be different for each
of RSV and influenza. Laboratory time series were lagged
in single weeks from -4 to +4 weeks to allow a reasonable
window for each virus to plausibly influence ED visits.
The final models for each ED syndrome outcome were of
the form:
where Yt denotes the weekly count of ED visits for the syn-
drome, β1 denotes the log relative risk of ED visits associ-
ated with a one-unit increase in laboratory confirmed
positive RSV infections, β2 denotes the log relative risk of
ED visits associated with a one-unit increase in laboratory
confirmed positive influenza infections, and S(time) is
the smoothing spline for time (in weeks). LagRSV and lag-
Influenza represent the lags at which the strongest associ-
ation occurred for the individual laboratory series.
Analysis was performed using the GAM procedure in SAS
version 9.1. This study used de-identified epidemiological
information and therefore ethical approval was not
required.
Results
Descriptive statistics
Visual inspection of the time-series of counts revealed
similar timing of the seasonal peaks for the ED bronchi-
olitis syndrome and laboratory RSV, but the peaks for lab-
oratory influenza occurred several weeks later (Figure 1).
The seasonal peaks for ED pneumonia syndrome occurred
after the peaks for laboratory RSV, but shortly before the
peaks for laboratory influenza. The seasonal peaks for ED
influenza-like syndrome occurred after the peaks for labo-
ratory RSV, and at a similar time to the peaks of laboratory
influenza. Compared with the all acute respiratory infec-
tion syndrome, and the all respiratory syndrome, the
peaks for laboratory RSV occurred earlier, while the peaks
for laboratory influenza occurred later.
The age distribution for the data is shown in Table 1. As
expected, the majority of RSV laboratory diagnoses
occurred in infants aged <1 year (65.1%), whereas influ-
enza laboratory diagnoses were fairly evenly distributed
amongst adults aged 17-34 years (20.4%), 35-64 years
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(25.8%), and 65+ years (24.4%). The bronchiolitis ED
syndrome mostly occurred in infants aged <1 year
(86.7%), the pneumonia syndrome mostly occurred in
adults aged 65+ years (43.2%), and the influenza-like syn-
drome mostly occurred in adults aged 17-34 years
(40.8%). The all acute respiratory infections syndrome,
and the all respiratory syndrome, mainly occurred in chil-
dren aged 1-4 years (30.1% and 23.2% respectively). The
proportions of ED visits admitted to hospital wards were
35.6% for the bronchiolitis, 5.8% for the influenza-like,
24.4% for the all acute respiratory infection, 34.6% for the
all respiratory, and 73.8% for the pneumonia ED syn-
dromes, respectively.
Influenza A virus accounted for the majority of positive
influenza laboratory cases (77.7%). Influenza B
accounted for 19.8% of the cases, while 2.5% were posi-
tive for both influenza A and B.
Weekly counts of Emergency Department (ED) syndromes and laboratory syndromes: 1 June 2001 to 1 December 2006 Figure 1
Weekly counts of Emergency Department (ED) syndromes and laboratory syndromes: 1 June 2001 to 1 
December 2006.BMC Infectious Diseases 2009, 9:190 http://www.biomedcentral.com/1471-2334/9/190
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Preliminary GAMs to determine lags with largest effects
The results of the preliminary analysis to establish the lags
for the final models are given in Table 2. Relative risks
refer to changes in ED visits resulting from every addi-
tional positive laboratory report for influenza and RSV.
ED bronchiolitis syndrome was most associated with RSV
laboratory counts in the same week (lag 0 week) (RR
1.031, 95%CI: 1.027-1.035), and with influenza labora-
tory counts four weeks in the future (lag -4 weeks) (RR:
1.007, 95%CI: 1.003-1.011). ED pneumonia syndrome
was most associated with RSV counts four weeks in the
past (lag + 4 weeks) (RR: 1.015, 95%CI: 1.012-1.018),
and with influenza laboratory counts one week in the
future (lag -1 week) (RR: 1.011, 95%CI: 1.008-1.013). ED
influenza-like syndrome was most associated with RSV
counts one week in the past (lag 1 week) (RR: 0.983,
95%CI: 0.976-0.990), and with influenza laboratory
counts one week in the future (lag -1 week) (RR: 1.047,
95%CI: 1.042-1.052). The all acute respiratory infections
and all respiratory syndromes were most associated with
RSV laboratory counts occurring two weeks in the past
(RR: 1.008, 95%CI: 1.006-1.009; and RR: 1.006, 95%CI:
1.005-1.007 respectively), and influenza laboratory
counts occurring one week in the future (RR: 1.012,
95%CI: 1.011-1.013; and RR: 1.009, 95%CI: 1.008-1.010
respectively).
Final GAMs
The results of the final models that included both RSV and
influenza are presented in Table 3. After controlling for
long term trend and seasonality, for every additional RSV
laboratory count, the bronchiolitis ED syndrome
increased by 3.1% (95%CI: 2.7%-3.5%) in the same
week, the pneumonia syndrome increased by 1.4%
(95%CI: 1.1%-1.7%) four weeks in the future, the influ-
enza-like syndrome decreased by 2.0% (95%CI: 1.3%-
2.8%) one week in the future, the all acute respiratory
infection syndrome increased by 0.6% (95%CI: 0.5%-
0.7%) two weeks in the future, and the all respiratory syn-
drome increased by 0.4% (95%CI: 0.3%-0.5%) two weeks
in the future.
After controlling for long term trend and seasonality, for
every additional influenza laboratory count, the bronchi-
olitis syndrome increased by 0.6% (95%CI: 0.3%-1.0%) 4
weeks in the past, the pneumonia syndrome increased by
1.0% (95%CI: 0.7%-1.2%) one week in the past, the
influenza-like syndrome increased by 4.7% (95%CI:
4.2%-5.2%) one week in the past, the all acute respiratory
infection syndrome increased by 0.6% (95%CI: 0.5%-
0.7%) one week in the past, and the all respiratory syn-
drome increased by 0.5% (95%CI: 0.4%-0.6%) one week
in the past.
Graphs representing the observed counts for ED visits ver-
sus the fitted (predicted) values for each of the final mod-
els are shown in Figures 2, 3, 4, 5, and 6. These figures
reveal good fit for each of the final models.
Discussion
By fitting time-series models which control for both
longer-term and seasonal effects, and which account for
the inherent auto-correlation in the data, we found a
large, significant, and independent association between
ED presentations for influenza and positive laboratory
tests for influenza viruses. We also found a large, signifi-
cant and independent association between ED presenta-
tions for bronchiolitis, and RSV laboratory counts. Thus
our results confirm the value of monitoring these more
specific syndromes in discriminating between influenza
and RSV activity in the population.
While the relative increases in ED visits in the bronchioli-
tis and influenza-like syndromes associated with a unit
increase in laboratory-identified RSV and influenza virus
were of the order of 3% and 5%, respectively, a small
increase in laboratory identified virus could actually rep-
resent a very large increase in population levels of illness.
This is because only a small proportion of people exposed
Table 1: Number (and percent total) per age group, for laboratory and Emergency Department (ED) syndrome data1.
Age group Laboratory 
influenza
Laboratory 
RSV
ED 
bronchiolitis
ED 
pneumonia
ED influenza-
like
ED acute 
respiratory 
infections
ED all 
respiratory
<1 yr 68 (4.8) 1021 (65.1) 4570 (86.7) 405 (3.2) 36 (2.1) 11531 (18.4) 13094 (11.9)
1-4 yrs 157 (11.1) 443 (28.3) 632 (12.0) 1961 (15.6) 103 (6.1) 18820 (30.1) 25509 (23.2)
5-16 yrs 189 (13.4) 38 (2.4) 21 (0.4) 1356 (10.8) 265 (15.8) 10976 (17.5) 17077 (15.5)
17-34 yrs 289 (20.4) 19 (1.2) 11 (0.2) 956 (7.6) 685 (40.8) 7517 (12.0) 15341 (13.9)
35-64 yrs 367 (25.9) 41 (2.6) 16 (0.3) 2446 (19.5) 489 (29.1) 6466 (10.3) 16168 (14.7)
65+ 345 (24.4) 6 (0.4) 23 (0.4) 5419 (43.2) 102 (6.1) 7278 (11.6) 22797 (20.7)
Total 1415 1568 5273 12543 1680 62588 109986
1. Source: ED data sourced from the NSW Emergency Department Data Collection. Laboratory Influenza data sourced from the NSW Notifiable 
Diseases Database. Laboratory RSV data sourced from the Eastern Sydney Laboratory Surveillance Program, NSW. Time period for all data: 1 June 
2001-1 December 2006.BMC Infectious Diseases 2009, 9:190 http://www.biomedcentral.com/1471-2334/9/190
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Table 2: Change in Emergency Department (ED) syndrome counts (relative risk (RR) and 95% CI) associated with a 1 unit increase in 
weekly laboratory counts, lagged by up to ± 4 weeks: Univariate analysis.
ED syndrome outcome Lag1 (weeks) RR RSV (95%CI) RSV P-value RR influenza (95%CI) Influenza
P-value
Bronchiolitis -4 1.009 (1.004-1.013) 0.0001 1.007 (1.003-1.011) < 0.0001
-3 1.015 (1.011-1.019) < 0.0001 1.003 (1.000-1.007) 0.075
-2 1.021 (1.017-1.026) < 0.0001 0.998 (0.994-1.001) 0.221
-1 1.025 (1.020-1.029) < 0.0001 0.999(0.995-1.003) 0.658
0 1.031 (1.027-1.035) < 0.0001 0.999 (0.995-1.003) 0.586
1 1.020 (1.016-1.024) < 0.0001 0.995 (0.990-0.999) 0.009
2 1.018 (1.014-1.022) < 0.0001 1.000 (0.996-1.005) 0.815
3 1.015 (1.011-1.019) < 0.0001 1.000 (0.995-1.004) 0.838
4 1.015 (1.011-1.019) < 0.0001 0.998 (0.994-1.003) 0.461
Pneumonia -4 0.998 (0.995-1.001) 0.1088 1.004 (1.002-1.007) 0.0005
-3 0.998 (0.995-1.001) 0.1611 1.007 (1.005-1.009) < 0.0001
-2 1.001 (0.998-1.004) 0.4498 1.010 (1.008-1.012) < 0.0001
-1 1.000 (0.997-1.003) 0.8307 1.011 (1.008-1.013) < 0.0001
0 1.004 (1.001-1.007) 0.0043 1.009 (1.007-1.012) < 0.0001
1 1.005 (1.002-1.008) 0.0008 1.007 (1.005-1.009) < 0.0001
2 1.011 (1.008-1.014) < 0.0001 1.003 (1.000-1.005) 0.0303
3 1.011 (1.008-1.013) < 0.0001 1.004 (1.002-1.007) 0.0011
4 1.015 (1.012-1.018) < 0.0001 0.999 (0.996-1.001) 0.3567
Influenza - like -4 1.009 (1.001-1.016) 0.0285 0.994 (0.988-1.000) 0.0383
-3 0.988 (0.981-0.996) 0.0031 1.011 (1.006-1.017) < 0.0001
-2 0.984 (0.976-0.991) < 0.0001 1.029 (1.024-1.034) < 0.0001
-1 0.984 (0.977-0.992) < 0.0001 1.047 (1.042-1.052) < 0.0001
0 0.991 (0.984-0.998) 0.0129 1.041 (1.036-1.046) < 0.0001
1 0.983 (0.976-0.990) < 0.0001 1.025 (1.020-1.031) < 0.0001
2 1.006 (0.999-1.012) 0.1129 1.025 (1.020-1.031) < 0.0001
3 1.002 (0.995-1.009) 0.5857 1.014 (1.008-1.020) < 0.0001
4 0.996 (0.989-1.002) 0.2172 0.999 (0.993-1.005) 0.655
All acute respiratory infections -4 0.998 (0.997-0.999) < 0.0001 1.003 (1.002-1.005) < 0.0001
-3 0.997 (0.996-0.998) < 0.0001 1.006 (1.005-1.007) < 0.0001
-2 0.999 (0.998-1.001) 0.2516 1.008 (1.007-1.009) < 0.0001
-1 1.002 (1.001-1.003) 0.0032 1.012 (1.011-1.013) < 0.0001
0 1.004 (1.003-1.005) < 0.0001 1.010 (1.009-1.011) < 0.0001
1 1.002 (1.001-1.003) 0.0053 1.007 (1.006-1.008) < 0.0001
2 1.008 (1.006-1.009) < 0.0001 1.005 (1.004-1.006) < 0.0001
3 1.007 (1.006-1.008) < 0.0001 1.003 (1.002-1.004) < 0.0001
4 1.006 (1.005-1.008) < 0.0001 0.999 (0.998-1.000) 0.0876
All respiratory -4 1.000 (0.999-1.001) 0.5467 1.003 (1.002-1.004) < 0.0001
-3 0.999 (0.998-1.000) 0.1499 1.005 (1.004-1.006) < 0.0001
-2 1.001 (1.000-1.002) 0.2258 1.007 (1.006-1.008) < 0.0001
-1 1.003 (1.002-1.004) < 0.0001 1.009 (1.008-1.010) < 0.0001
0 1.005 (1.004-1.005) < 0.0001 1.007 (1.006-1.008) < 0.0001
1 1.002 (1.001-1.003) 0.001 1.004 (1.004-1.005) < 0.0001
2 1.006 (1.005-1.007) < 0.0001 1.003 (1.002-1.004) < 0.0001
3 1.006 (1.005-1.006) < 0.0001 1.001 (1.000-1.002) 0.0198
4 1.005 (1.004-1.006) < 0.0001 0.998 (0.997-0.999) < 0.0001
1A negative lag number refers to virus counts occurring after ED visits, while a positive lag number refers to virus counts occurring before ED visits.BMC Infectious Diseases 2009, 9:190 http://www.biomedcentral.com/1471-2334/9/190
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to the virus and infected are likely to attend an ED and an
even smaller proportion are likely to be tested for a virus.
The other, smaller associations found in this study are
more difficult to interpret. In the period we studied, RSV
laboratory counts peaked before influenza laboratory
counts, and RSV was associated with ED diagnoses of
pneumonia several weeks later. Hence, it is possible that
RSV infection may increase subsequent susceptibility to
influenza infection or pneumonia, although other studies
are needed to investigate this further.
The relatively small associations found between labora-
tory RSV and influenza counts, and the all acute respira-
tory infection and all respiratory syndromes indicate that
there are many other factors driving the increase in these
ED visits which have not been accounted for in the mod-
els for these two syndrome outcomes. These other factors
may include additional circulating respiratory pathogens,
environmental contributors including temperature, or
holidays. The inclusion of the previous week's ED visits in
the GAM models for both of these syndromes was
required to remove autocorrelation in the residuals, and
represents the contribution of these unmeasured factors.
For influenza, our findings were consistent with our pre-
vious work using a similar date range and state-wide data,
Table 3: Change in ED visits (Relative risk and 95%CI) associated with a 1 unit increase in weekly laboratory counts: final models.
ED syndrome outcome Covariates (lag, weeks) RR (95%CI) P-value
Bronchiolitis RSV (0) 1.031 (1.027-1.035) < 0.0001
Influenza (-4) 1.006 (1.003-1.010) 0.001
Pneumonia RSV (+4) 1.014 (1.011-1.017) < 0.0001
Influenza (-1) 1.010 (1.007-1.012) < 0.0001
Influenza - like RSV (+1) 0.980 (0.972-0.987) < 0.0001
Influenza (-1) 1.047 (1.042-1.052) < 0.0001
All respiratory RSV (2) 1.004 (1.003-1.005) < 0.0001
Influenza (-1) 1.005 (1.004-1.006) < 0.0001
All respiratory ED visits 1 week prior 1.001 (1.001-1.001) < 0.0001
All acute respiratory infections RSV (2) 1.006 (1.005-1.007) < 0.0001
Influenza (-1) 1.006 (1.005-1.007) < 0.0001
All respiratory ED visits 1 week prior 1.002 (1.002-1.002) < 0.0001
1Only lags between -4 and +4 weeks were considered in this study.
Observed versus predicted values for bronchiolitis ED visits  by week: 1 June 2001 to 1 December 2006 Figure 2
Observed versus predicted values for bronchiolitis 
ED visits by week: 1 June 2001 to 1 December 2006.
Observed versus predicted values for pneumonia ED visits by  week: 1 June 2001 to 1 December 2006 Figure 3
Observed versus predicted values for pneumonia ED 
visits by week: 1 June 2001 to 1 December 2006.BMC Infectious Diseases 2009, 9:190 http://www.biomedcentral.com/1471-2334/9/190
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and a different, but sound, statistical method [8]. Our
findings were also broadly consistent with those of Wijn-
gaard et al [9] who also controlled for autocorrelation in
their regression model. They found a 1-2 week advantage
for hospitalisations diagnosed with any acute respiratory
illness over laboratory-identified influenza. For RSV, they
found that the hospitalisations increased in the same
week as laboratory-identified RSV.
The data sources used in this study may have some limita-
tions. Since RSV data was only available for the south-
eastern area of Sydney, the scope of our study was limited
to this region. Therefore, due to small numbers, analysis
by age group for instance was not possible. Another limi-
tation is that ED provisional diagnoses were selected by
ED medical, nursing or clerical staff in the course of their
work, and selection of codes may vary between staff and
hospitals. Limitations for the ED data and laboratory
influenza data are discussed further in [8].
Our decision to use GAMs in this study was based on the
flexibility they provide through the use of nonparametric
regression. The problem with using a parametric
approach, such as sinusoidal terms to control for season-
ality, is that this assumes that the seasonal peak is the
same height and occurs at the same time each year [28]. It
can clearly be seen from the time-series graphs (Fig. 1)
that this is not the case in our data, and is probably not the
case in these time series generally.
Conclusion
In conclusion, syndromic surveillance of ED visits diag-
nosed with influenza or bronchiolitis can give a reasona-
ble assurance that influenza and RSV, respectively, are
circulating in the population, and can be used to discrim-
inate between them. This finding is particularly useful in
our state, where RSV infection is not a reportable disease
and near real-time ED surveillance is a reality [4].
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